课题基金 / 基金详情

Research on the elucidation of molecular pathomechanism of and the development of therapy of lysosomal muscle diseases.

Research on the elucidation of molecular pathomechanism of and the development of therapy of lysosomal muscle diseases.
溶酶体肌肉疾病分子病理机制阐明及治疗进展研究。
批准号:
16209029
负责人:
NISHINO Ichizo
金额:
$28.87万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

NISHINO Ichizo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We group lysosomal muscle disease into autophagic vacuolar myopathy (AVM) and rimmed vacuolar myopathy (RVM).For AVM, we focused on developing a therapy for Danon disease (primary LAMP・deficiency) by overexpressing LAMP・, a homolog of LAMP・. We first evaluated the physiological performance of skeletal muscle of LAMP・knockout (KO) mice. Although their maximum motor performance did not statistically differ from controls, their endurance was much lower. Analysis of isolated muscles showed that the contractile force similar to control. Pathologically, autophagic vacuoles were prominent in muscle fibers, as seen in human patients. We next generated LAMP-1 transgenic (Tg) mice. LAMP-1 Tg mice were born normally and did not show any phenotype. We cross-mated LAMP-2KO and LAMP・Tg mice and successfully obtained LAMP2 KO mice overexpressing LAMP-1. These mice showed better endurance than LAMP・KO mice, strongly suggesting that LAMP-1 overexpression may compensate for the phenotype, at least in skeletal muscle.For RVM, we evaluated the lysosomal abnormalities in distal myopathies with rimmed vacuoles (DMRV). DMRV is an autosomal recessive disease pathologically characterized by rimmed vacuoles and amyloid deposition on light microscopy, and tubulofilamentous inclusion bodies on electron microscopy. The disease is caused by missense mutations in GNE gene. We recently established DMRV model mice which lacked their own GNEbut expressed human GNEwith V572L mutation, which is the most common mutation among Japanese DMRV patients. We investigated the pathomechanism of DMRV focusing on autophagy and amyloid deposition in the skeletal muscles using our DMRV mice. Amyloid deposition preceded rimmed vacuole formation, indicating that amyoloid is depeosited prior to autophagic process. In addition, these lysosomal accumulations were seen mainly in type 2B fibers. This pattern was similar to that seen in LAMP・KO mouse, suggesting a common pathomechamism between RVM and AVM.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
Reduction of UDP-GlcNAc 2-epimerase/ManNAc kinase activity and sialylation in distal myopathy with rimmed vacuoles.
具有边缘空泡的远端肌病中 UDP-GlcNAc 2-差向异构酶/ManNAc 激酶活性和唾液酸化的降低。
DOI: --
发表时间: 2004
期刊: J Biol Chem 279
影响因子: --
作者: [Noguchi S, et al.]
通讯作者: et al.
DOI: 10.1212/01.wnl.0000115386.28769.65
发表时间: 2004-03-23
期刊: NEUROLOGY
影响因子: 9.9
作者: [Kim, DS, Hayashi, YK, Nishino, I]
通讯作者: Nishino, I
Central core disease is due to RYR1 mutations in more than 90% of patients
中央%20核心%20疾病%20is%20due%20to%20RYR1%20突变%20in%20more%20比%2090%%20of%20患者
DOI: --
发表时间: 2006
期刊: Brain 129
影响因子: --
作者: [Wu S, et al.]
通讯作者: et al.
縁取り空砲を伴う遠位型ミオパチーの原因遺伝子と分子病態
边缘空白远端肌病的致病基因和分子病理学
DOI: --
发表时间: 2004
期刊: ゲノム医学 4
影响因子: --
作者: [Mori T, Kita T, Sawaguchi T, 西野一三]
通讯作者: 西野一三
25
    Elucidation of molecular pathomechanism and development of therapy for collagen VI deficiency
    • 批准号:
      26293214
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2014
    • 负责人:
      NISHINO Ichizo
    • 依托单位:
    Elucidation of pathomechanism of and development of therapy ofautophagy-related muscle disorders
    • 批准号:
      20390250
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2008
    • 负责人:
      NISHINO Ichizo
    • 依托单位:
    The elucidation of pathomechanism and the development of therapy of myopathies with autophagic abnormalities
    国内基金
    海外基金
    基于FGL2-THBS1-Autophagy信号通路探索复方清痹片治疗 类风湿关节炎的效应及机制研究
    自噬流/炎症小体失衡在新生儿缺血缺氧性脑病中的作用机制
    • 批准号:
      82372205
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      崔德荣
    • 依托单位:
    SIRT2/Annexin A2/autophagy通路形成的分子机制及其在HCC细胞失巢凋亡抵抗中的作用研究
    组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
    • 批准号:
      82370988
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      经典
    • 依托单位: